IPCXR vs SYK · rev $100.0M vs P/E 35, rev $6.59B
Inflection Point Acquisition Corp. III Rights (IPCXR) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Inflection Point Acquisition Corp. III Rights (IPCXR) common stock listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported IPCXR revenue for 2025-09-30 was $100.0M. Net income was -$90.8K. IPCXR currently screens at market cap $0.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
IPCXR currently screens at market cap $0. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the IPCXR and SYK stock pages for the full models.
Not investment advice.